Candidates must have obtained at least an upper Second Class Honours (2:1) Grade or equivalent in an honours BSc in Biotechnology, Biochemistry, Microbiology, Genetics, Neuroscience, Physiology, Pharmacology, Medicinal Chemistry or an equivalent qualification.
If English is not your native language, unless you have done your primary degree through English in an English speaking country, an English language qualification is required for all programmes. English Language qualifications include a minimum score of 550 (213 computer based) for Test of English as a Foreign Language (TOEFL), or 6.5 (with a score of 6 obtained in each category) for International English Language Testing System (IELTS). Other evidence of proficiency in English may be accepted such as the Cambridge Certificate. Tests used as evidence of language proficiency must have been comp
2 academic references will be required, at least one to be from a science faculty member.
Students meeting the programme’s academic entry requirements but not the English language requirements, may enter the programme upon successful completion of UCD’s Pre-Sessional or International Pre-Master’s Pathway programmes. Please see the following link for further information
http://www.ucd.ie/alc/programmes/pathways/
These are the minimum entry requirements – additional criteria may be requested for some programmes
Students will be able to demonstrate a comprehensive understanding of business principles as they relate to the biotherapeutics industry Students will be able to apply their knowledge to overcome problems with commercialisation of research in a biotherapeutics focus area Students will be able to conduct applied studies on valuation of new drug entities from the biotherapeutics industry Students will be able to analyse, evaluate and communicate biotechnology research Students will be able to work alongside scientists and entrepreneurs to develop and commercialise novel biotechnological solutions Students will be able to develop effective time management, problem-solving and reporting skills as required in a professional workplace Students will be able to develop a professional approach to engaging with industry and an applied methodology in preparing for employment opportunities This graduate degree in Biotherapeutics & Business has been developed in consultation with employers and therefore will be recognised and valued by them. A key feature is the opportunity to carry out a business development plan, which will allow graduates to develop connections with prospective employers, thereby enhancing chances of employment on graduation. Prospective employers include Abbott, Allergan, Amgen, Baxter Healthcare, Eli Lilly and Co., Dignity Sciences, GSK, Icon Clinical Research, ImmunoGen Inc., Janssen Pharmaceutical Ltd., Johnson & Johnson Ltd., MSD, Quintiles, Quest International, Sandoz and Seroba Life Sciences. Below is a list of all modules offered for this degree in the current academic year. Click on the module to discover what you will learn in the module, how you will learn and assessment feedback profile amongst other information. Incoming Stage 1 undergraduates can usually select an Elective in the Spring Trimester. Most continuing undergraduate students can select up to two Elective modules (10 Credits) per stage. There is also the possibility to take up to 10 extra Elective credits.